EUSA Pharma Aims To Grow Through Acquisitions In Specialty Rx Market
This article was originally published in The Pink Sheet Daily
Executive Summary
EUSA Pharma announced the launch of operations March 23 with a group of products acquired from Jazz Pharmaceuticals and funding from equity investor Essex Woodlands; it is the third specialty pharma company set up by U.K. entrepreneur Bryan Morton.